User profiles for S. H. Fox
Susan FoxAssociate Professor University of Toronto Verified email at uhnresearch.ca Cited by 26222 |
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
…, M Coelho, S Perez‐Lloret, SH Fox… - Movement …, 2011 - Wiley Online Library
The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine (EBM)
Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and was …
Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and was …
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
The objective was to update previous evidence‐based medicine reviews of treatments for
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (…
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (…
International Parkinson and movement disorder society evidence‐based medicine review: update on treatments for the motor symptoms of Parkinson's disease
Objective: The objective of this review was to update evidence‐based medicine recommendations
for treating motor symptoms of Parkinson's disease (PD). Background: The Movement …
for treating motor symptoms of Parkinson's disease (PD). Background: The Movement …
Four multidetector-row helical CT: image quality and volume coverage speed
H Hu, HD He, WD Foley, SH Fox - Radiology, 2000 - pubs.rsna.org
PURPOSE: To evaluate the imaging performance characteristics of four multidetector-row
helical computed tomography (CT) and assess improvement in volume coverage speed over …
helical computed tomography (CT) and assess improvement in volume coverage speed over …
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
…, K Ray Chaudhuri, M Coelho, SH Fox… - Movement …, 2019 - Wiley Online Library
Objective To update evidence‐based medicine recommendations for treating nonmotor
symptoms in Parkinson's disease (PD). Background The International Parkinson and Movement …
symptoms in Parkinson's disease (PD). Background The International Parkinson and Movement …
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
C Zadikoff, SH Fox, DF Tang‐Wai… - Movement …, 2008 - Wiley Online Library
Dementia is an important and increasingly recognized problem in Parkinson's disease (PD).
The mini‐mental state examination (MMSE) often fails to detect early cognitive decline. The …
The mini‐mental state examination (MMSE) often fails to detect early cognitive decline. The …
Medication-related impulse control and repetitive behaviors in Parkinson disease
A range of behaviors presumed to be related to aberrant or excessive dopaminergic medications
are being increasingly recognized in Parkinson disease. These behaviors are linked by …
are being increasingly recognized in Parkinson disease. These behaviors are linked by …
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study
The lateral segment of the globus pallidus (GPl) is thought to be overactive in levodopa-induced
dyskinesia in PD. Stimulation of cannabinoid receptors in the GPl reduces γ-…
dyskinesia in PD. Stimulation of cannabinoid receptors in the GPl reduces γ-…
Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease
…, JM Miyasaki, M de Souza, A Shafro, SH Fox… - Archives of …, 2007 - jamanetwork.com
… Analysis and interpretation of data: Voon, Shafro, Fox, and Lang. Drafting of the manuscript:
Voon and Shafro. Critical revision of the manuscript for important intellectual content: Voon, …
Voon and Shafro. Critical revision of the manuscript for important intellectual content: Voon, …
Clinical spectrum of levodopa‐induced complications
… Susan Fox has received financial support for consultancy, advisory boards and speaker
fees from Astra Zeneca Merck Serono, Novartis, Teva, Medtronic, Zambon. Research funding …
fees from Astra Zeneca Merck Serono, Novartis, Teva, Medtronic, Zambon. Research funding …